Tradr Launches Leveraged ETFs on Bloom Energy, Celestica, NANO Nuclear & Synopsys Nov 13, 2025 06:46AM
Synaptogenix (SNPX) Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 Jun 26, 2024 09:01AM
Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis Jun 26, 2024 09:00AM